The decision follows a positive EFSA safety assessment delivered on 13 September 2012, which concluded that the use level for Zeaxanthin does not raise safety concerns.
This opens up the 27 EU-member state market to DSM’s Zeaxanthin brand Optisharp.
Together with Lutein, Zeaxanthin is one of the main components of the macular pigment selectively deposited into the human macula. It is found in a small, highly sensitive area of the retina responsible for central vision where it works as a blue light filter and as an antioxidant.
Source: DSM
© FoodBev Media Ltd 2024